SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-029583
Filing Date
2019-06-04
Accepted
2019-06-04 06:10:02
Documents
19
Period of Report
2019-06-04

Document Format Files

Seq Description Document Type Size
1 6-K tv523027_6k.htm 6-K 44321
2 GRAPHIC image_001.jpg GRAPHIC 317360
3 GRAPHIC image_002.jpg GRAPHIC 182729
4 GRAPHIC image_003.jpg GRAPHIC 258394
5 GRAPHIC image_004.jpg GRAPHIC 235480
6 GRAPHIC image_005.jpg GRAPHIC 129884
7 GRAPHIC image_006.jpg GRAPHIC 183163
8 GRAPHIC image_007.jpg GRAPHIC 175601
9 GRAPHIC image_008.jpg GRAPHIC 220911
10 GRAPHIC image_009.jpg GRAPHIC 167962
11 GRAPHIC image_010.jpg GRAPHIC 386989
12 GRAPHIC image_011.jpg GRAPHIC 227966
13 GRAPHIC image_012.jpg GRAPHIC 257608
14 GRAPHIC image_013.jpg GRAPHIC 207019
15 GRAPHIC image_014.jpg GRAPHIC 293347
16 GRAPHIC image_015.jpg GRAPHIC 427832
17 GRAPHIC image_016.jpg GRAPHIC 152154
18 GRAPHIC image_017.jpg GRAPHIC 185706
19 GRAPHIC logo.jpg GRAPHIC 4397
  Complete submission text file 0001144204-19-029583.txt   5576508
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 19875218
SIC: 2834 Pharmaceutical Preparations